3rd Annual Bio Cross-border Investment & Partnership Summit
Co-hosted by BayHelix and MSQ
Dec 15th 12:30PM~2:30PM EST
Dec 16th Beijing time 9:30AM~1:30PM (Dec 15th 8:30PM~12:30AM EST)
Agenda
Part 1
Princeton In person BayHelix Group Reception
Date: Dec 15th 12:30PM~2:30PM EST
Location: Princeton
12:30PM~12:40PM Opening Speech
BayHelix Vision and Goals
Tony Chen(Chairman, BayHelix Group)
BayHelix NY/NJ/PA 2022 Plan
Echo Hindle-Yang(Co-head of BayHelix NY/NJ/PA )
12:40PM~2:30PM Dinner & Network
Part 2
Online Event
Dec 16th 9:30AM-1:30PM Beijing time
9:30AM~9:40AM Opening Speech
Tony Chen (Chairman, BayHelix Group)
Echo Hindle-Yang (Founder & CEO, MSQ Ventures)
9:40AM~10:20AM Panel Discussion I
Topic: How does China joining the ICH Impact the Dynamics of Global Clinical Trial Design?
Host: Alvin Luk (Neurophth, CEO)
Speakers:
Roger Luo (Overland Pharmaceuticals, CDO)
Whitney Page (G1 Therapeutics, Head of Alliance Management)
Xin-Yuan Fu (GenEros Biopharma, Chairman & Founder)
Oliver Kong (Qilu Pharmaceuticals, Chief Medical Officer)
10:20AM~11:00AM Company Presentation
1# Presentation @10:20AM
Radiopharm Theranostics
Speaker: Riccardo Canevari (CEO)
Topic: Innovative Biotech Start-up with deep pipeline in Radiopharmaceuticals
2# Presentation @10:30AM
Ionis Pharmaceuticals
Speaker: Paul Park (Vice President of BD)
Topic: Partnering with Ionis: a pioneer in RNA-targeted drug discovery and development
3# Presentation @10:45AM
Neoleukin Therapeutics, Inc.
Speaker: Jonathan Drachman (CEO)
Topic: A pioneering approach to building custom protein for cancer immunotherapy
11:00AM~11:30AM Expert Talk
Topic: Biotech Hong Kong IPO: Common Legal Issues
Yiming Liu (Cooley, Partner )
11:30AM~12:10PM Panel Discussion II
Topic: A Leap from Regional to Global Deals: China Biopharma’s Licensing Strategy Revolution
Host: Ginger Ding(Managing Director, MSQ Ventures)
Speakers:
Eddy Wu (Arctic Vision, CEO)
James Xue (CANbridge Pharmaceuticals, Founder, Chairman and CEO)
Bing Yuan (Oncusp Therapeutics, Co-Founder, Chairman, CEO)
Ye Hua (BioNova, CEO)
12:10PM~1:45PM Company Presentation
4# Presentation @12:10PM
Neurophth Therapeutics, Inc.
Speaker: Alvin Luk (CEO)
Topic: Neurophth Therapeutics introduction
5# Presentation @12:25PM
Ultimovacs
Speaker: Ton Berkien (Chief Business Officer)
Topic: “Off-the-shelf” cancer vaccine: Activating the immune system to fight cancer
6# Presentation @12:40PM
D&D Pharmatech
Speaker: Yoo Seok Hong (CEO)
Topic: Development of innovative, first-in-class therapeutics for neurodegeneration and fibrotic diseases
7# Presentation@12:55PM
Destiny Pharma
Speaker: Neil Clark (CEO)
Topic: “Prevention is better than cure”: developing novel medicines to prevent life-threatening infections
8# Presentation@1:05PM
FluoGuide
Speaker: Morten Albrechtsen (CEO)
Topic: Maximizing cancer surgical outcome: intelligent targeting
9# Presentation@1:15PM
Enyo Pharma
Speaker: Pete Leone (Head of Business Development & Licensing)
Topic: An anti-inflammatory and anti-fibrotic FXR agonist in liver and kidney diseases
10# Presentation@1:25PM
AB2 Bio
11# Presentation@1:35PM
Chimeric Therapeutics
Speaker: Jennifer Chow (CEO)
Topic: Leading CAR-T and CAR-NK Cell Therapy Pipeline
12# Presentation@1:45PM
ViCardia Therapeutics Inc.
Speaker: Michael Kokesh (Founder & CEO)
Topic: Addressing the underlying cause of heart failure, with a focus on mitochondrial dysfunction and AMPK activation
Please find the full agenda here